BIOMARIN PHARMACEUTICAL INC Financing Receivable, Past Due
BIOMARIN PHARMACEUTICAL INC (BMRN) had Financing Receivable, Past Due of $11.40 million as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Notes
us-gaap:FinancingReceivableRecordedInvestmentPastDue · last filed 2015-03-02
- 2014-12-31: Financing Receivable, Past Due $11.40M.
- 2014-09-30: Financing Receivable, Past Due $10.60M.
- 2014-06-30: Financing Receivable, Past Due $9.80M.
- 2014-03-31: Financing Receivable, Past Due $3.01M.
| Period end | Financing Receivable, Past Due |
|---|---|
| 2014-12-31 | $11.40M 10-K · filed 2015-03-02 |
| 2014-09-30 | $10.60M 10-Q · filed 2014-10-28 |
| 2014-06-30 | $9.80M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $3.01M 10-Q · filed 2014-05-02 |
| 2013-12-31 | $5.99M 10-K · filed 2014-02-26 |
| 2013-09-30 | $5.23M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $4.13M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $3.52M 10-Q · filed 2013-04-29 |
| 2012-12-31 | $2.54M 10-K · filed 2013-02-26 |
| 2012-09-30 | $3.11M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $2.20M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $5.28M 10-Q · filed 2012-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |